Bank of New York Mellon’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $771K | Buy |
158,354
+106,043
| +203% | +$516K | ﹤0.01% | 3248 |
|
2025
Q1 | $194K | Buy |
52,311
+241
| +0.5% | +$892 | ﹤0.01% | 3874 |
|
2024
Q4 | $208K | Hold |
52,070
| – | – | ﹤0.01% | 3914 |
|
2024
Q3 | $363K | Sell |
52,070
-17,037
| -25% | -$119K | ﹤0.01% | 3664 |
|
2024
Q2 | $392K | Buy |
+69,107
| New | +$392K | ﹤0.01% | 3691 |
|
2022
Q4 | – | Sell |
-3,057
| Closed | -$21K | – | 4540 |
|
2022
Q3 | $21K | Hold |
3,057
| – | – | ﹤0.01% | 4449 |
|
2022
Q2 | $28K | Sell |
3,057
-9,836
| -76% | -$90.1K | ﹤0.01% | 4452 |
|
2022
Q1 | $232K | Sell |
12,893
-329
| -2% | -$5.92K | ﹤0.01% | 4162 |
|
2021
Q4 | $347K | Buy |
13,222
+27
| +0.2% | +$709 | ﹤0.01% | 4015 |
|
2021
Q3 | $473K | Buy |
13,195
+2,283
| +21% | +$81.8K | ﹤0.01% | 3840 |
|
2021
Q2 | $599K | Buy |
10,912
+4,730
| +77% | +$260K | ﹤0.01% | 3685 |
|
2021
Q1 | $513K | Sell |
6,182
-579
| -9% | -$48K | ﹤0.01% | 3669 |
|
2020
Q4 | $769K | Buy |
6,761
+1,490
| +28% | +$169K | ﹤0.01% | 3399 |
|
2020
Q3 | $161K | Buy |
5,271
+33
| +0.6% | +$1.01K | ﹤0.01% | 3888 |
|
2020
Q2 | $230K | Sell |
5,238
-330
| -6% | -$14.5K | ﹤0.01% | 3761 |
|
2020
Q1 | $199K | Buy |
5,568
+701
| +14% | +$25.1K | ﹤0.01% | 3735 |
|
2019
Q4 | $324K | Buy |
4,867
+248
| +5% | +$16.5K | ﹤0.01% | 3768 |
|
2019
Q3 | $716K | Sell |
4,619
-131
| -3% | -$20.3K | ﹤0.01% | 3349 |
|
2019
Q2 | $410K | Buy |
4,750
+1,272
| +37% | +$110K | ﹤0.01% | 3691 |
|
2019
Q1 | $480K | Sell |
3,478
-302
| -8% | -$41.7K | ﹤0.01% | 3569 |
|
2018
Q4 | $1.52M | Buy |
3,780
+995
| +36% | +$400K | ﹤0.01% | 2867 |
|
2018
Q3 | $1.97M | Buy |
2,785
+659
| +31% | +$466K | ﹤0.01% | 2835 |
|
2018
Q2 | $1.14M | Buy |
2,126
+782
| +58% | +$418K | ﹤0.01% | 3181 |
|
2018
Q1 | $152K | Buy |
+1,344
| New | +$152K | ﹤0.01% | 3974 |
|